Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence and latency.
Mocarski ES Jr, Abenes GB, Manning WC, Sambucetti LC, Cherrington JM. Mocarski ES Jr, et al. Among authors: cherrington jm. Curr Top Microbiol Immunol. 1990;154:47-74. doi: 10.1007/978-3-642-74980-3_3. Curr Top Microbiol Immunol. 1990. PMID: 2161325 Review. No abstract available.
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.
Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES. Sambucetti LC, et al. Among authors: cherrington jm. EMBO J. 1989 Dec 20;8(13):4251-8. EMBO J. 1989. PMID: 2556267 Free PMC article.
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.
Cherrington JM, Mocarski ES. Cherrington JM, et al. J Virol. 1989 Mar;63(3):1435-40. doi: 10.1128/JVI.63.3.1435-1440.1989. J Virol. 1989. PMID: 2536844 Free PMC article.
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site.
Cherrington JM, Khoury EL, Mocarski ES. Cherrington JM, et al. J Virol. 1991 Feb;65(2):887-96. doi: 10.1128/JVI.65.2.887-896.1991. J Virol. 1991. PMID: 1846203 Free PMC article.
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
Ning S, Laird D, Cherrington JM, Knox SJ. Ning S, et al. Among authors: cherrington jm. Radiat Res. 2002 Jan;157(1):45-51. doi: 10.1667/0033-7587(2002)157[0045:taasas]2.0.co;2. Radiat Res. 2002. PMID: 11754641
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T, Fuller MD, Mulato AS, Cherrington JM. Cihlar T, et al. Among authors: cherrington jm. Virology. 1998 Sep 1;248(2):382-93. doi: 10.1006/viro.1998.9299. Virology. 1998. PMID: 9721246
Regulation of polyadenylation in human immunodeficiency virus (HIV): contributions of promoter proximity and upstream sequences.
Cherrington J, Ganem D. Cherrington J, et al. EMBO J. 1992 Apr;11(4):1513-24. EMBO J. 1992. PMID: 1373376 Free PMC article.
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.
Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J. Deeks SG, et al. Among authors: cherrington jm. J Infect Dis. 1997 Dec;176(6):1517-23. doi: 10.1086/514150. J Infect Dis. 1997. PMID: 9395363 Clinical Trial.
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T, Fuller MD, Cherrington JM. Cihlar T, et al. Among authors: cherrington jm. J Virol. 1998 Jul;72(7):5927-36. doi: 10.1128/JVI.72.7.5927-5936.1998. J Virol. 1998. PMID: 9621055 Free PMC article.
Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
Itokawa T, Nokihara H, Nishioka Y, Sone S, Iwamoto Y, Yamada Y, Cherrington J, McMahon G, Shibuya M, Kuwano M, Ono M. Itokawa T, et al. Among authors: cherrington j. Mol Cancer Ther. 2002 Mar;1(5):295-302. Mol Cancer Ther. 2002. PMID: 12489845
74 results
Jump to page
Feedback